Bafna Pharmaceuticals Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Bafna Pharmaceuticals Ltd. on BSE

Load latest

Bafna Pharmaceuticals Ltd.

11 Sep 2023

125.35

4.99%

Company Update

BAFNA PHARMACEUTICALS LTD. - 532989 - Filing Of Report Under Regulation 7(2)(B) Securities And Exchange Board …

BSE India

We here by submit the attached disclosure received under Regulation 7(2)(a) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, from SRJR Lifesciences LLP, one of the promoters of Bafna Pharmaceuticals Limited, ("the Company"), regarding disposal Equity shares of the Company. This submission is pursuant to Regulation 7(2)(b) of SEBI(Prohibition of Insider Trading) Regulations, 2015, as amended.

pdf

Bafna Pharmaceuticals Ltd.

11 Sep 2023

125.35

4.99%

SAST

BAFNA PHARMACEUTICALS LTD. - 532989 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SRJR Lifesciences LLP

pdf

Bafna Pharmaceuticals Ltd.

06 Sep 2023

125.35

4.99%

Company Update

BAFNA PHARMACEUTICALS LTD. - 532989 - Notice of Offer for sale of shares by Promoter & …

BSE India

Notice of the proposed Offer for Sale of equity shares of face value of Rs. 10 each ("Equity Shares") of Bafna Pharmaceuticals Ltd (the "Company") by its Promoter, SRJR Lifesciences LLP, through the stock exchange mechanism (the "Notice")

pdf

Bafna Pharmaceuticals Ltd.

31 Aug 2023

125.35

4.99%

Company Update

BAFNA PHARMACEUTICALS LTD. - 532989 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Copies of the Newspaper publication ''Notice - Dispatch of notice of 28th Annual General Meeting, Annual Report 2022-23, Remote e-Voting instructions, and Cut-off date'' published in the Newspapers viz., Business Standard (English, all editions) and Makkal Kural(Tamil, Chennai edition) on August 31, 2023.

pdf

Bafna Pharmaceuticals Ltd.

30 Aug 2023

125.35

4.99%

Corp. Note

BAFNA PHARMACEUTICALS LTD. - 532989 - Reg. 34 (1) Annual Report.

BSE India

As informed in our letter referred above, the 28th Annual General Meeting (AGM) of the Company is scheduled to be held on Friday, September 22, 2023, at 10:25 a.m. through Video Conference/ Other Audio-Visual Means. We wish to confirm that the following documents have been circulated to the members by electronic mode, today, i.e., August 30, 2023, and we are submitting herewith the said documents for the financial year ended 2022-23, pursuant to Regulation 30 and 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circular No. SEBI Circular No. SEBI/HO/CFD/PoD-2/P/CIR/2023/4 dated January 05, 2023: i. Notice of 28th Annual General Meeting (duly covering the instructions for remote e-Voting, e-voting during the meeting and instructions for attending the AGM through Video Conference). ii. Annual Report.

pdf

Bafna Pharmaceuticals Ltd.

13 Aug 2023

125.35

4.99%

Company Update

BAFNA PHARMACEUTICALS LTD. - 532989 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

We have furnished herewith newspaper clippings of Un-audited Standalone Financial Results of the Company for the 1st quarter ended June 30, 2023, and published in the newspapers, namely, Makkal Kural (Tamil edition) Business Standard (English edition) on Saturday, August 12, 2023.

pdf

Bafna Pharmaceuticals Ltd.

12 Aug 2023

125.35

4.99%

Result

BAFNA PHARMACEUTICALS LTD. - 532989 - Financial Results For The Quarter Ended June 30, 2023.

BSE India

the Board of Director of Bafna Pharmaceuticals Limited approved the Financial results for the quarter ended June 30, 2023.

pdf

Bafna Pharmaceuticals Ltd.

11 Aug 2023

125.35

4.99%

Company Update

BAFNA PHARMACEUTICALS LTD. - 532989 - Delay In Submission Of Related Party Transactions For The Year …

BSE India

The Board noted the issue of non-compliance with the Regulation 23(9) of SEBI (LODR) Regulations, 2015

pdf

Bafna Pharmaceuticals Ltd.

11 Aug 2023

125.35

4.99%

AGM

BAFNA PHARMACEUTICALS LTD. - 532989 - Shareholder Meeting - AGM On Friday, September 22, 2023.

BSE India

the 28th Annual General Meeting of the Members of the Company will be held on Friday, September 22, 2023, at 10:25 am IST, through Video Conferencing (VC)/ Other Audio-Visual Means (OAVM).

pdf

Bafna Pharmaceuticals Ltd.

11 Aug 2023

125.35

4.99%

Board Meeting

BAFNA PHARMACEUTICALS LTD. - 532989 - Board Meeting Outcome for Approval Of Financials For The Quarter …

BSE India

We wish to inform that at the meeting of the Board of Directors of the Company held today i.e., August 11, 2023, Friday, the results for the quarter ended on June 30, 2023, duly reviewed and recommended by the Audit Committee, inter-alia, has been considered and approved by the Board of Directors of the Company.

pdf

Is Bafna Pharmaceuticals Ltd. worth buying?

24 Votes:

Buy 66.67%

Sell 25.0%

Hold 8.33%